Detalhe da pesquisa
1.
Postexposure Administration of a Yersinia pestis Live Vaccine for Potentiation of Second-Line Antibiotic Treatment Against Pneumonic Plague.
J Infect Dis
; 220(7): 1147-1151, 2019 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31095689
2.
Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague.
PLoS Pathog
; 11(5): e1004893, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25974210
3.
Adjunctive Corticosteroid Treatment Against Yersinia pestis Improves Bacterial Clearance, Immunopathology, and Survival in the Mouse Model of Bubonic Plague.
J Infect Dis
; 214(6): 970-7, 2016 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27402776
4.
Transendothelial migration of effector T cells across inflamed endothelial barriers does not require heparan sulfate proteoglycans.
Int Immunol
; 26(6): 315-24, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24402310
5.
Rapid Induction of Protective Immunity against Pneumonic Plague by Yersinia pestis Polymeric F1 and LcrV Antigens.
Vaccines (Basel)
; 11(3)2023 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36992165
6.
Phage Therapy Potentiates Second-Line Antibiotic Treatment against Pneumonic Plague.
Viruses
; 14(4)2022 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35458417
7.
An Improvement in Diagnostic Blood Culture Conditions Allows for the Rapid Detection and Isolation of the Slow Growing Pathogen Yersinia pestis.
Pathogens
; 11(2)2022 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35215198
8.
Screening of an FDA-Approved Library for Novel Drugs against Y. pestis.
Antibiotics (Basel)
; 10(1)2021 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33401634
9.
Novel RNA Extraction Method for Dual RNA-seq Analysis of Pathogen and Host in the Early Stages of Yersinia pestis Pulmonary Infection.
Microorganisms
; 9(10)2021 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34683487
10.
Fc-Independent Protection from SARS-CoV-2 Infection by Recombinant Human Monoclonal Antibodies.
Antibodies (Basel)
; 10(4)2021 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34842604
11.
Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice.
iScience
; 24(5): 102479, 2021 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33937725
12.
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody.
Nat Commun
; 12(1): 944, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33574228
13.
Development of Improved Devices for Handling and Restraining Experimental Laboratory Mice.
Appl Biosaf
; 25(1): 53-58, 2020 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36033382
14.
Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments.
Sci Rep
; 10(1): 19116, 2020 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33154422
15.
A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes.
Nat Commun
; 11(1): 4303, 2020 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32855401
16.
Disruption of the NlpD lipoprotein of the plague pathogen Yersinia pestis affects iron acquisition and the activity of the twin-arginine translocation system.
PLoS Negl Trop Dis
; 13(6): e0007449, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31170147
17.
Early Diagnosis of Pathogen Infection by Cell-Based Activation Immunoassay.
Cells
; 8(9)2019 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31443439
18.
Targeting of the Yersinia pestis F1 capsular antigen by innate-like B1b cells mediates a rapid protective response against bubonic plague.
NPJ Vaccines
; 3: 52, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30374415
19.
Inhalational Gentamicin Treatment Is Effective Against Pneumonic Plague in a Mouse Model.
Front Microbiol
; 9: 741, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29740404
20.
Disparity between Yersinia pestis and Yersinia enterocolitica O:8 in YopJ/YopP-dependent functions.
Adv Exp Med Biol
; 603: 312-20, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17966427